Overview

A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation

Status:
Not yet recruiting

Trial end date:
2023-03-03

Target enrollment:

Participant gender:

Summary

This is a multi-center, randomized, open-label, propofol-controlled exploratory clinical study. In this study, 20 ICU patients undergoing mechanical ventilation are expected to be enrolled and will be randomly assigned to the HSK3486 group and the propofol group in a 1:1 ratio. This study is not blinded as it is open-label.

Phase:

Phase 2

Details

Lead Sponsor:

Haisco Pharmaceutical Group Co., Ltd.

Treatments:

Propofol